Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis
Heather A. Leitch, Christopher Chan, Chantal S. Leger, Lynda M. Foltz, Khaled M. Ramadan, Linda M. VickarsVolume:
36
Year:
2012
Language:
english
DOI:
10.1016/j.leukres.2012.08.001
File:
PDF, 379 KB
english, 2012